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Abstract 
Background 
The Temperament Evaluation Memphis, Pisa, Paris and San Diego Auto-questionnaire (TEMPS) is 
validated to assess temperament in clinical and non-clinical samples. Scores vary across bipolar 
disorder (BD), major depressive disorder (MDD), attention-deficit/hyperactivity disorder (ADHD), 
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borderline personality disorder (BPD) and healthy controls (HCs), but a meta-analysis is missing. 
Methods 
Meta-analysis of studies comparing TEMPS scores in patients with mood disorders or their first-
degree relatives to each other, or to a psychiatric control group or HCs. 
Results 
Twenty-six studies were meta-analyzed with patients with BD (n=2,025), MDD (n=1283), ADHD 
(n=56) and BPD (n=43), relatives of BD (n=436), and HCs (n=1757). Cyclothymic (p<0.001) and 
irritable TEMPS scores (p<0.001) were higher in BD than MDD (studies=12), and in MDD vs HCs 
(studies=8). Cyclothymic (p<0.001), irritable (p<0.001) and anxious (p=0.03) scores were higher in 
BD than their relatives, who, had higher scores than HCs. No significant differences emerged 
between ADHD and BD (studies=3); 
Conclusion 
Affective temperaments are on a continuum, with increasing scores ranging from HCs through 
MDD to BD regarding cyclothymic and irritable temperament, from MDD through BD to HC 
regarding hyperthymic temperament, and from HC through BD relatives to BD regarding 
cyclothymic, irritable and anxious temperament. Depressive and anxious temperaments did not 
differ between BD and MDD, being nonetheless the lowest in HCs. BD did not differ from ADHD 
in any investigated TEMPS domain.  
Limitations 
different TEMPS versions, few studies comparing BD with ADHD or BPD, no correlation with 
other questionnaires. 
Keywords: Affective temperament; Temperament Evaluation Memphis; Pisa; Paris and San Diego 
Auto-questionnaire; 110 item version (TEMPS-A-110); TEMPS; Major depression: bipolar 
disorder. 
 
1. Introduction 
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The “Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego” (TEMPS) has been 
extensively validated to evaluate sub-affective trait expressions as they were conceptualized in 
Ancient Greek psychological medicine and, in more recent times, by Nineteenth Century German 
psychiatry (Akiskal and Akiskal 2007, Rihmer, Akiskal et al. 2010).  
The TEMPS has been developed based on the “Interview” version (TEMPS-I) released in the late 
1990s (Akiskal, Placidi et al. 1998, Placidi, Signoretta et al. 1998), which was subsequently 
extended to include 84 items (Akiskal and Akiskal 2005), and ultimately leading to the current 110-
item version of the TEMPS-A (Akiskal and Akiskal 2005, Akiskal, Akiskal et al. 2005). The 
TEMPS-A includes five domains and items, which serve as criteria for the cyclothymic, dysthymic, 
irritable, hyperthymic and anxious temperaments (Akiskal and Mallya 1987, Cassano, Akiskal et al. 
1992). The TEMPS-A characterizes the dominant temperament of a subject, which results in a 
frequency of each temperament within a given population (e.g., about 10% of BP-II patients have 
cyclothymic temperament vs. 1% of healthy individuals (Mechri, Kerkeni et al. 2011)).  
The TEMPS-A has been validated for use in both healthy people and those with a psychiatric 
diagnosis, in several languages and different settings, and has consistently demonstrated acceptable 
psychometric properties (Akiskal and Mallya 1987, Akiskal, Placidi et al. 1998). The theoretical 
construct of the TEMPS-A refers to a constitutional, genetically-determined, biological personality 
substrate of the individual reflecting an “endophenotype” trait that is stable across the lifespan 
(Nuttin 1985). Though void of any intrinsic psychopathological predictive value (Rutter 1987), the 
predominant affective temperament holds a place in the multifactorial model of mood disorders, 
mapping onto the subclinical extreme of the continuum that encompasses bipolar disorder type I 
(BD-I), type-II BD (BD-II), and major depressive disorder (MDD) on the opposite pole, including 
also other mood disorders not yet officially accepted (BD-III, IV) (Akiskal, Akiskal et al. 2006) or, 
possibly, the affective core of distinct diagnostic entities, such as borderline personality disorder 
(BDP) (Perugi, Fornaro et al. 2011) or, even, attention-deficit/hyperactivity disorder (ADHD)  
(Landaas, Halmoy et al. 2012, Ekinci, Ozdel et al. 2013). 
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From this perspective, varying combinations of affective temperamental domains could 
represent vulnerability markers to different disorders, especially cyclothymic temperament for BD-
II or hyperthymic temperament for euphoric mania BD-I (Perugi, Maremmani et al. 2001), and 
could help differential diagnosis among mood disorders (Perugi, Toni et al. 2012). Nonetheless, 
although stable across the lifespan (Kawamura, Akiyama et al. 2010) and highly genetically-
determined (Gonda, Rihmer et al. 2006) even in “affected or unaffected” first-degree relatives 
(Vazquez, Kahn et al. 2008), it is unclear whether the actual continuum proposed for affective 
temperaments across varying psychopathological and non-psychopathological conditions might be 
actually reflected by a progressive severity of scores. 
 
To the best of our knowledge, no meta-analysis exists evaluating the TEMPS scores across patients 
with BD or MDD, patients with different psychiatric diagnoses, BD relatives and HCs.  The present 
paper aimed to address this gap and provide the first quantitate report investigating the existence of 
a metric continuum of the different scores of the five essential domains of the TEMPS. 
 
METHODS 
The present meta-analysis adhered to the MOOSE guidelines (Stroup, Berlin et al. 2000) and 
PRISMA statement (Moher, Shamseer et al. 2015), following a predetermined, but unpublished 
protocol.    
 
Search strategy and study selection 
Two authors (MS, LZ) independently searched Scopus and PubMed from inception until August 
1st, 2015 using the search terms ("temperament"[All Fields] OR "character"[All Fields]) AND 
("depression" OR "major depression" OR "depressive disorder" OR "affective disorder" OR 
"bipolar disorder" OR "bipolar" OR mania OR "mood disorder"). The reference list of included 
articles and of recent reviews were checked for potentially eligible studies. Studies eligible for 
inclusion provided the following: i) administration of the TEMPS (any validated version) to patients 
with either BD or MDD or their first-degree relatives compared to each other or compared to ii) 
healthy controls (HCs); iii) other psychiatric disorders.   
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Data extraction 
Two authors (MS, LZ) independently extracted data using a data extraction form, including: author, 
publication year , country, setting, demographic characteristics for BD and control groups (age, 
number of males, sample size), mean and SD of TEMPS scores in each group. When we identified 
an article that was eligible but did not contain sufficient data to enable inclusion in the meta-
analysis, we contacted the corresponding authors up to three times over a month to request the data. 
 
Outcome measures and quality assessment 
The primary outcome measure was the study-based standardized mean difference (SMD) of each 
TEMPS score between patients with BD, MDD or their first-degree relative and each available 
control group. The study quality was independently assessed by two authors (LZ and MS) using a 
modified version of the Newcastle Ottawa Scale (NOS) (Wells, Shea et al. 2000). Our version of 
the scale was modified (NOS-M) (see Supplementary Material 1) to produce a score ranging from 0 
(lowest quality) to 18 (highest quality), which was determined for each study by consensus between 
the two investigators. 
 
Meta-analytic method 
The meta-analysis was conducted in the following steps. First, we calculated the SMD statistic 
together with 95% confidence interval (CI) to establish the difference in each TEMPS affective 
temperament domain score, between patients with BD or MDD or their first-degree relatives and 
control groups, with RevMan (Review Manager, v5.2) (RevMan). Second, we conducted meta-
regression analyses with Comprehensive meta-analysis (CMA, version 3, http://www.meta-
analysis.com) (CMA)to investigate the following moderators: sex, phase of the disease in both BD 
and MDD, country of origin. Heterogeneity was assessed with I
2
 statistics for each analysis, with a 
value of >50% indicating high heterogeneity (Higgins, Thompson et al. 2003). Publication bias was 
assessed with a visual inspection of funnel plots and with the Begg-Mazumdar Kendall's tau (Begg 
and Mazumdar 1994) and Egger bias test (Egger, Davey Smith et al. 1997).  In case of significant 
findings indicating publication bias, we calculated the trim and fill adjusted analysis (Duval and 
Tweedie 2000) in order to evaluate if the results changed after imputing potentially missing studies. 
 
RESULTS 
Selection of studies and retrieved sample 
The study selection process is shown in Figure1. Characteristics of included studies and patients are 
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reported in table 1. We included 26 studies in the meta-analysis (Evans, Akiskal et al. 2005, 
Kesebir, Vahip et al. 2005, Matsumoto, Akiyama et al. 2005, Benazzi 2006, Karam, Salamoun et al. 
2010, Ekinci, Ozdel et al. 2013, Fornaro, Ventriglio et al. 2013, Greenwood, Badner et al. 2013, 
Kesebir, Gundogar et al. 2013, Mahon, Perez-Rodriguez et al. 2013, de Aguiar Ferreira, 
Vasconcelos et al. 2014, Eich, Gamma et al. 2014, Harnic, Pompili et al. 2014, Kesebir, Tatlidil 
Yaylaci et al. 2014, Dolenc, Dernovšek et al. 2015, Innamorati, Rihmer et al. 2015) (Mendlowicz, 
Akiskal et al. 2005, Mendlowicz, Jean-Louis et al. 2005, Nowakowska, Strong et al. 2005, 
Vazquez, Kahn et al. 2008, Mazzarini, Pacchiarotti et al. 2009, Nilsson, Jorgensen et al. 2010, 
Pompili, Innamorati et al. 2014, Russo, Mahon et al. 2014, Rybakowski, Kaminska et al. 2014, Xu, 
Lu et al. 2014). The included studies contained 5628 subjects, including 2025 with BD, 43 with 
BPD, 56 with ADHD, 1283 with MDD, 28 with ED, 1757 HC, 436 relatives of patients with BD.  
Seven studies were carried out in the US or Canada, 6 studies in Italy, 4 in Turkey, and 1 each in 
Brazil, Slovenia, Switzerland, Lebanon, Japan, Denmark, Poland, Argentina, and China. Most of 
the included studies included only outpatients (22/26, 84.6%). Twelve studies compared BD vs 
MDD, 3 studies provided also data about BD-I compared to BD II, 14 studies compared BD vs HC, 
8 studies compared MDD vs HC, 16 studies investigated TEMPS scores in BD compared to 
ADHD, BPD, or ED, 4 studies compared patients with BD vs their relatives, and 4 studies 
compared relatives of patients with BD vs HC (see table 2 for all references). 
 
TEMPS-A-110, a self-administered version of TEMPS (or no further specified version of the 
TEMPS-A) questionnaire was used in 14 studies (Evans, Akiskal et al. 2005, Nowakowska, Strong 
et al. 2005, Benazzi 2006, Ekinci, Ozdel et al. 2013, Fornaro, Ventriglio et al. 2013, Greenwood, 
Badner et al. 2013, Mahon, Perez-Rodriguez et al. 2013, Eich, Gamma et al. 2014, Harnic, Pompili 
et al. 2014, Pompili, Innamorati et al. 2014, Russo, Mahon et al. 2014, Rybakowski, Kaminska et 
al. 2014, Dolenc, Dernovšek et al. 2015, Innamorati, Rihmer et al. 2015). The other 9 studies used 
the TEMPS – Rio de Janeiro in 1 study (de Aguiar Ferreira, Vasconcelos et al. 2014); TEMPS-A 
Rome in 1 study (Fornaro, Ventriglio et al. 2013); Lebanese-Arabic TEMPS-A in 1 study (Karam, 
Salamoun et al. 2010); Turkish version of TEMPS-A in 3 studies (Kesebir, Vahip et al. 2005, 
Kesebir, Gundogar et al. 2013, Kesebir, Tatlidil Yaylaci et al. 2014); Japanese version of TEMPS-A 
in 1 study (Matsumoto, Akiyama et al. 2005); Italian version of TEMPS-A in 1 study (Mazzarini, 
Pacchiarotti et al. 2009); short version of TEMPS-A in 3 studies (Mendlowicz, Akiskal et al. 2005, 
Mendlowicz, Jean-Louis et al. 2005, Nilsson, Jorgensen et al. 2010); TEMPS-A Buenos Aires in 1 
study (Vazquez, Kahn et al. 2008); and the Chinese version of TEMPS-A in 1 study (Xu, Lu et al. 
2014). 
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Detailed information about the study quality is provided in Supplementary e-Table 2. 
Comparison of affective temperament scores across diagnostic groups 
All results are reported in detail in table 2 and those of particular interest are summarized below. 
Bipolar Disorder vs Major Depressive Disorder 
The meta-analysis pooled data from 12 studies (n=2204), except for the anxious TEMPS scores, for 
which only 10 studies provided data (n=1660). Patients with BD had significantly higher 
cyclothymic (SMD=0.54 [0.38, 0.71], P<0.00001; I²=65%, P=0.0009), hyperthymic (SMD=0.39 
[0.18, 0.60], P=0.0002; I²=78%, P<0.00001), and irritable (SMD=0.41 [0.22, 0.60], P<0.0001; 
I²=73%, p<0.0001) TEMPS scores compared to patients with MDD. Depressive (P=0.29) and 
anxious (P=0.54) TEMPS scores were not different between the two groups. 
Bipolar Disorder Type I vs Bipolar Disorder Type II 
The meta-analysis pooled data from 3 studies (n=671), except for anxious TEMPS scores for which 
only 2 studies provided data (n=443). Depressive TEMPS scores were significantly lower in BD-I 
compared to BD-II (SMD= -0.25 [-0.41, -0.09], P=0.002; I²=0%, P=0.61). Cyclothymic (P=0.29), 
hyperthymic (P=0.12), irritable (P=0.84), anxious (P=0.72) TEMPS scores were not different 
between BD-I and BD-II. 
Bipolar Disorder vs Healthy Controls 
The meta-analysis pooled data from 14 studies (n=2452), except for anxious TEMPS scores, for 
which only 12 studies provided data (n=1928).  Cyclothymic (SMD=2.22 [1.61, 2.84], P<0.00001; 
I²=97%, P<0.00001), depressive (SMD=1.19 [0.55, 1.82], P=0.0002; I²=97%, P<0.00001), irritable 
(SMD=1.29 [0.86, 1.72], P<0.00001; I²=95%, P<0.00001), and anxious (SMD=1.38 [0.66, 2.09], 
P=0.0002; I²=97%, P<0.00001) TEMPS scores were significantly higher in the BD group than in 
HCs. Conversely, hyperthymic TEMPS scores were significantly lower in the BD group compared 
to HCs (SMD=-0.44 [-0.74, -0.15], P=0.004; I²=90%; P<0.00001). 
Major Depressive Disorder vs Healthy Controls 
The meta-analysis pooled data from 8 studies (n=1901), except for anxious TEMPS score, for 
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which only 6 studies provided data (n=1344). 
Cyclothymic (SMD=0.90 [0.60, 1.20], P<0.00001; I²=87%, P<0.00001), depressive (SMD=1.29 
[0.87, 1.71], P<0.00001; I =93%, P<0.00001), irritable (SMD=0.52 [0.04, 1.00], P=0.03; I²=95%, 
P<0.00001), and anxious (SMD=1.01 [0.53, 1.48], P<0.0001; I²=93%, P<0.00001) TEMPS scores 
were significantly higher in the MDD group than in HCs. Conversely, hyperthymic TEMPS scores 
were significantly lower in the MDD group compared to HCs (SMD=-0.68 [-0.85, -0.50], 
P<0.00001; I²=61%; P=0.01). 
BD vs Psychiatric Disorders Other than MDD 
The meta-analysis pooled data from 6 studies (n=262), with  3 studies comparing BD vs ADHD 
(n=126), 2 studies comparing BD vs BPD (n=80), 1 study comparing BD vs ED (n=56). 
Compared to ADHD, the BD group did not differ regarding cyclothymic (p=0.43), hyperthymic 
(p=0.86), depressive (p=0.79), irritable (p=0.07), or anxious (p=0.40) TEMPS scores. 
Compared to BPD, the BD group had significantly higher hyperthymic (SMD=0.69 [0.23, 1.14], 
P=0.003; I²=0%, P=0.81) TEMPS scores, and significantly lower depressive (SMD=-1.24 [-1.73, -
0.76], P<0.00001; I²=0%; p=0.67), irritable (SMD=-0.91 [-1.38, -0.45], P=0.0001; I²=0%, p=0.46), 
and anxious (SMD=-1.42 [-1.91, -0.92], P<0.00001; I²= %, P=0.43) TEMPS scores. Conversely, 
cyclothymic TEMPS scores did not differ between BPD and BD (P=0.19). 
Only one study reported data about TEMPS scores in ED, so a subgroup MA was not meaningful. 
Finally, subgroup difference analyses showed that MDD, ADHD, BPD and ED differed 
significantly  from BD regarding cyclothymic (p=0.01), hyperthymic (P<0.00001), depressive 
(P=0.0002), irritable (P<0.00001), and anxious (P<0.0001) TEMPS scores. 
 
BD vs First-degree BD Relatives 
Meta-analysis pooled data from 4 studies (n=795). Cyclothymic (SMD=2.89 [1.48-4.29], P<0.0001; 
I²=98%, P<0.00001), irritable (SMD=1.90 [0.77, 3.04], P=0.001; I²=98%, P<0.00001), and anxious 
(SMD=2.71 [0.23, 5.18], P=0.03; I²=99%, P<0.00001) TEMPS scores were significantly higher in 
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the BD group compared to BD relatives. Hyperthymic (P=0.97) and depressive (not significant after 
the trim and fill procedure; P=0.09 TEMPS scores did not differ between BD and BD relatives. 
First-degree BD Relatives vs Healthy Controls 
The meta-analysis pooled data from 4 studies (n=1018). Cyclothymic (SMD=1.54 [0.43, 2.65], 
P=0.007; I² = 98%, P<0.00001), irritable (SMD=[0.48, 1.47], P=0.0001 after the trim and fill 
procedure) and anxious (SMD=2.11 [0.50, 3.72] P=0.01 after the trim and fill procedure) TEMPS 
scores were significantly higher in BD relatives than in HCs. Hyperthymic (P=0.12) and depressive 
(P=0.97) TEMPS scores did not differ between BD relatives and HCs. 
Heterogeneity and publication bias 
No comparison between BD-I and BD-II had an I²>50%. All comparisons between BD and MDD, 
BD and HC, MDD and HC, BD vs relatives, and BD relatives vs HC had an I²>50%. 
Begg-Mazumdar Kendall's tau (Begg and Mazumdar 1994), Egger’s bias test (Egger, Davey Smith 
et al. 1997) and the trim and fill method (Duval and Tweedie 2000) did not substantially change the 
direction and significance of the results in any comparison. 
 
Moderator variables 
Results of the meta-regression analyses are reported in table 3.  Briefly, in BD vs MDD non-
European study origin moderated lower hyperthymic TEMPS scores (N=12, β=-0.44 [-0.82-0.06], 
R²=0.28, P=0.02). The moderator effect was confirmed by t-test comparison between the SMD in 
the BD and MDD groups, according to meta-regression strata (P=0.04) (e-table 3). 
In BD vs HC comparisons, male sex in HCs (N=10, β=0.05 [0.01-0.08], R²=0.00, P=0.01) 
moderated higher cyclothymic TEMPS scores, but the R²=0.00 indicated that results were 
quantitatively irrelevant. Non-European study origin (N=14, β=1.29 [0.12-2.46] R²=0.18, P=0.03), 
and male sex in HCs (N=10, β=0.03 [0.005-0.06], R²=0.16, P=0.02) moderated higher depressive 
TEMPS scores. Furthermore, non-European study origin moderated higher irritable (N=14, β=1.00 
[0.201.81], R²=0.18, P=0.01) and anxious (N=12, β=1.87 [0.75-3.00], R²=0.40, P=0.001) TEMPS 
scores. Higher anxious TEMPS scores were also significantly moderated by male sex in HCs (N=8, 
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β=0.05 [0.01-0.08], R²=0.24, p=0.009). The moderator effect of non-European study origin was not 
confirmed by t-test comparison between SMD in BD and HCs regarding depressive scores 
(P=0.07), while it was confirmed with irritable (P=0.005) and anxious (P=0.001) TEMPS scores 
according to meta-regression strata (Supplementary table 3). 
 
In MDD vs HC comparisons, non-European study origin moderated higher cyclothymic (N=8, 
β=0.56 [0.03-1.14] R²=0.24, P=0.04) and anxious (n=6, β=0.82 [0.14-1.50], R²=0.55, P=0.02) 
TEMPS scores. In MDD vs HC comparisons, active depression compared to euthymia moderated 
lower irritable (N=5, β=-1.44 [-2.3- -0.6], R²=0.76, p=0.001), and anxious (N=4, β=-1.03 [-2.02 - -
0.04], R²=0.43, p=0.04) TEMPS scores. Also, male sex in HCs (N=4, β=0.05 [0.02 - 0.07], 
R²=0.78, p=0.003) moderated higher anxious scores. The moderator effect of non-European study 
origin was confirmed by t-test comparison between SMD in MDD and HCs, according to meta-
regression strata in cyclothymic (P=0.008) and anxious (P=0.02) scores (Supplementary table 3). 
 
In BD patients vs relatives comparisons, non-European study origin moderated higher anxious 
TEMPS scores (N=4, β=6.27 [4.74 - 7.81], R²=0.94, P<0.001), and the effect was confirmed by t-
test comparison between SMD in BD patients and relatives according to meta-regression strata 
(P<0.001) (Supplementary table 3). 
In BD relatives vs HC comparisons, non-European study origin moderated lower depressive scores 
(N=4, β=-2.08 [-3.86 - -0.29], R²=0.69, p=0.02), and the effect was confirmed by t-test comparison 
between SMD in BD relatives and HCs according to meta-regression strata (P<0.001) 
(Supplementary table 3). 
Discussion 
The results of the first meta-analysis of TEMPS affective scores across mood disorders and 
pertinent control groups suggest a continuum model of affective temperament domains spanning 
from HCs through MDD to BD. Cyclothymic and irritable domain score severities appear to 
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progressively increase according the above mentioned pattern. The same continuum trajectory was 
observed for cyclothymic, irritable and anxious temperament that each ranged from HCs, through 
BD relatives, to patients affected by BD, further strengthening the genetic and heritable component 
as one of the underlying factors that contribute to the multifactorial pathogenesis of BD 
(Greenwood, Akiskal et al. 2012, Greenwood, Badner et al. 2013). Nonetheless, the above 
mentioned trend was not replicated with respect to depressive and anxious temperament domains. 
Conversely, the depressive and anxious domains appear cluster across mood disorders as a group, 
with similar scores in BD and MDD, which were both significantly higher compared to HCs. A 
possible interpretation of this finding may be a selection bias, i.e., the inclusion of moderate to 
severe clinical cases of BD and MDD, rather than of milder presentations. In fact, it has been 
proposed that higher scores in the cyclothymic, irritable and hyperthymic TEMPS domains 
correlate significantly with more severe BD presentations (Perugi, Toni et al. 2012), suggesting the 
possibility of some degree of state dependent effects in the upper severity range in addition to 
underlying, more stable, trait-dependent temperament  ratings. 
The finding of higher hyperthymic temperament scores n BD than MDD follow the mood polarity 
of disorder. However, we also found that HCs had even higher hyperthymic ratings than BD 
patients. This seeming disconnect is likely due to the fact that BD patients were not always 
euthymic and that BD more frequent presents with depressive or mixed features than with pure 
(hypo)mania (Judd, Akiskal et al. 2002, Judd, Akiskal et al. 2003, Judd, Akiskal et al. 2005),s,  
previously described as the “dark side of hypomania” (Hantouche, Angst et al. 2003, Cassano, Mula 
et al. 2009). Moreover, patients with atypical depression or BD-II depression appear to have a 
strong relationship with cyclothymic temperament, whereas BD-I and manic patients have more 
consistently been related to higher hyperthymic scores. This latter relationship could explain the 
lower hyperthymic scores in the included BD group compared to HCs, considering that only 4 
studies reported separate scores for BD I and BD II.  
Pertaining to the continuum model, our results confirm previously hypotheses of increasing 
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temperamental features across diseases and from diseases through relatives to healthy populations, 
which is a core feature of an endophenotype (Di Florio, Hamshere et al. 2010). Also, since 
noncompliance has been recognized as a frequent  and core problem in BD management (Levin, 
Tatsuoka et al. 2015, Sajatovic, Levin et al. 2015), and since cyclothymic temperament has been 
associated with poor treatment adherence (Fornaro, De Berardis et al. 2013), the cyclothymic 
TEMPS subscale could possibly be a useful tool in everyday practice, warning about  the risk of 
non-adherence, prompting more careful monitoring, supervision or medication switches from oral 
to long-acting formulations where available. Even more importantly, cyclothymic temperament is a 
recognized risk factor for suicidal behavior, being associated with hopelessness beyond polarity in 
BD. Again, here the cyclothymic TEMPSS subscore could be helpful clinically in increasing 
surveillance or influencing treatment choice, including lithium (Koek, Yerevanian et al. 2012). 
Furthermore, the observed temperamental patterns can at least partially explain similarities and 
differences within the mood disorder group. Both BD and MDD spend major parts of the illness in 
the depressive phase (Judd, Akiskal et al. 2002, Judd, Akiskal et al. 2003, Judd, Akiskal et al. 
2005), likely relating to  the similar depressive temperament ratings. Conversely, our results 
confirm that, as previously suggested (de Aguiar Ferreira, Vasconcelos et al. 2014) temperament 
measures are useful in the differential diagnosis between BD and MDD; with significantly higher 
TEMPS hyperthymic, cyclothymic and irritable domain sores in BD than MDD. Rating these 
temperamental domains could be useful in particular clinical situations, such as presentation with 
depressed mood, where distinguishing unipolar from bipolar disorder is key decision factor for 
treatment decisions, yet, this differentiation can be quite challenging (Hirschfeld 2014). 
Regarding the BD vs ADHD comparisons, our results strongly suggest common temperamental 
features, as indicated before (Landaas, Halmoy et al. 2012), suggesting some shared biological 
background between the two conditions that are also not infrequently comorbid, especially in youth 
(Ashcroft, Verdolini et al. 2015, Chen, Chen et al. 2015, Lan, Bai et al. 2015). Moreover, although 
only two studies reported data about TEMPS-A in BD vs BPD, our preliminary results suggest that 
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temperament assessments could be helpful in helping to distinguish these two conditions, in 
addition to taking into consideration a history of childhood sexual abuse, childhood 
depersonalization, personality variables relating to interpersonal difficulties and sensitivity to 
criticism, BD family history, and interpersonal features (Bayes, McClure et al. 2015). 
Limitations 
Results of this study need to be interpreted within its limitations. First, we only investigated 
TEMPS affective domains, excluding other potentially interesting questionnaires, such as the 
Tridimensional Cloninger Inventory (Cloninger, Svrakic et al. 1993). However affective domains as 
measured by TEMPS have consistent biological and genetic correlates (Gonda, Rihmer et al. 2006, 
Greenwood, Akiskal et al. 2012, Greenwood, Badner et al. 2013), being a fundamental instrument 
to “look into brain through the mind’s lens”.  Second, included studies did not all use all the same 
TEMPS version. However, former studies have shown consistent reliability of different TEMPS 
versions (Vahip, Kesebir et al. 2005) (Akiskal, Akiskal et al. 2005, Krebs, Kazes et al. 2006, 
Vazquez, Nasetta et al. 2007, Figueira, Caeiro et al. 2008, Borkowska, Rybakowski et al. 2010, 
Preti, Vellante et al. 2010, Lin, Xu et al. 2013), supporting our choice to pool the results across 
these different TEMPS versions. Moreover, we accounted for heterogeneity of measurement 
instruments using random effect model in meta-analysis, and  our publication bias and trim and fill 
analyses confirmed the results. Third, comparisons between BD and ADHD, and between BD and 
BPD only included 3 and 2 studies, respectively, limiting the validity and generalizability of these 
results. This sample size limitation is accentuated by the fact that BD, BPD and ADHD have 
overlapping features and that controversy exists about the appropriate nosological boundaries  
(Bayes, McClure et al. 2015). Fourth, a deeper insight into the affective temperament can be gained 
from combining data from different structured questionnaires, such as the TEMPS and TCI. Such 
analyses have already shown significant correlations between novelty seeking and harm avoidance, 
on the one hand, and anxious, depressive and cyclothymic temperament domains, on the other 
(Rozsa, Rihmer et al. 2008). However, such analyses are beyond the aims and scope of this meta-
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analysis. Fifth, the vast majority of studies included outpatients, possibly introducing a bias, which, 
however, was not apparent in our subgroup and moderator analyses. Sixth, not all included studies 
specified inclusion criteria for first degree-relatives, with two studies (Kesebir, Vahip et al. 2005, 
Mahon, Perez-Rodriguez et al. 2013) including first degree relatives and siblings, whereas the other 
two studies did not provide further details about the nature of the familial relationship. We 
attempted to contact authors, but were unable to obtain clarification, assuming for the purposes of 
the analyses that the studies included first degree-relatives, in line with the aims of investigating 
temperament as an endophenotype and as stable trait across families. Finally, while it would be of 
great interest to assess TEMPS scores in patients with and without a family history of bipolar 
disorder, this level of detail was unavailable in the meta-analyzed studies, precluding such subgroup 
analyses.  
Despite these limitations, several strengths of this study are also noteworthy. First, to the authors’ 
knowledge, this is the first meta-analysis of studies comparing TEMPS ratings in within and across 
mood disorders and in comparison to psychiatric controls and HCs. Second, this study identified 
different patterns of TEMPS scores in different diseases and in comparison to HC. Third, this 
metaanalysis confirms the continuum pattern of cyclothymic, irritable and anxious temperament, 
ranging from the lowest scores in HCs, through relatives of patients with BD, to patients affected by 
MDD and to patients with BD. Fourth,  the sample size and the number of studies included in the 
analyses were robust for most of the analyses and comparisons, at least versus HCs and comparing 
BD with MDD.  
Conclusions 
In conclusion, affective temperament as measured by TEMPS has a continuum pattern increasing in 
severity from HC, through MDD to BD regarding cyclothymic and irritable temperament, from 
MDD through BD to HC regarding hyperthymic temperament, and from HC through BD relatives 
to BD regarding cyclothymic, irritable and anxious domains. BD did not differ from MDD 
regarding depressive and anxious temperament, but these two affective domains separated both 
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mood disorder from HCs who scored far lower than both MDD and BD. BD did not differ from 
ADHD in any of the investigated TEMPS domains, suggesting a common biological background, 
although more data are needed to confirm this. Finally, BPD was associated with higher depressive, 
anxious, and irritable temperament scores compared to BD, lower hyperthymic scores, but similar 
cyclothymic scores. However only two studies compared these  two populations, underscoring the 
need for further studies investigating the overlap and differentiating features across severe mental 
disorders and, especially, BPD and BD. 
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TABLE1. Main characteristics of included studies reporting TEMPS data in patients with mood 
disorders. 
Study / 
Country 
Design 
Inclusion 
Criteria for 
Primary 
Mood 
Disorder 
Patients 
Inclusion 
Criteria 
for 
Control 
Group 
Exclusion 
Criteria 
Illness 
Phase 
BD 
Illness 
Phase 
MDD 
NOS
-M 
N BD 
N 
BPD 
N 
ADH
D 
N 
MDD 
N 
Buli
mia 
or 
ANB
P 
N HC 
N 
Relati
ves 
Benazzi 
2006      Italy 
CS 
outpatien
ts 
BD-II, GAF 
>80 
MDD  - 
Euthym
ic 
Euthym
ic 
11.0
0 
138..
00 
 -  - 
71..0
0 
 -  -  - 
De Aguiar 
2014    Brazil 
CS 
outpatien
ts 
BD, 
HAMD>17 
and YMRS 
<8, at least 
Dep 
Episode 
MDD  - 
Euthym
ic 
Euthym
ic 
13.0
0 
90..0
0 
 -  - 
88..0
0 
 -  -  - 
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Study / 
Country 
Design 
Inclusion 
Criteria for 
Primary 
Mood 
Disorder 
Patients 
Inclusion 
Criteria 
for 
Control 
Group 
Exclusion 
Criteria 
Illness 
Phase 
BD 
Illness 
Phase 
MDD 
NOS
-M 
N BD 
N 
BPD 
N 
ADH
D 
N 
MDD 
N 
Buli
mia 
or 
ANB
P 
N HC 
N 
Relati
ves 
with 
antidepres
sants for at 
least 8 
weeks 
Dolenc 2015  
Slovenia 
CS 
outpatien
ts 
EuthymicB
D 
Euthymic, 
MDD 
not 
stable, 
not 
remission 
for at 
elast 6 
months, 
psychiatri
c 
comorbidi
ty, 
pregnant 
women. 
Euthym
ic 
Euthym
ic 
13.0
0 
64..0
0 
 -  - 
36..0
0 
 -  -  - 
Ecinki 2013   
Turkey 
CS 
outpatien
ts 
>17yo, BD I 
euthymic 
HAMD<7 
YMRS<5, 
ADHD, 
DSM-IV,  
 ADHD  - 
Euthym
ic 
 - 16 40  - 40  -  - 40  - 
Eich 2014 
Switzerland 
CS  
out+inpati
ents 
Euthymic 
BD, DSM-
IV, ICD10, 
Utah 
BPD, 
ADHD 
 - 
Euthym
ic 
 - 10 
24 
(pure
12) 
27 
(pure
12) 
23 
(pure
10) 
 -  -  -  - 
Evans 2005           
US, Canda 
CS 
outpatien
ts 
Families 
with BD I, 
BD II 
HC: No 
mood 
disorder, 
no 
relatives 
with 
mood 
disorder 
 -  NA  - 9.00 
155..
00 
 -  -  -  -  -  - 
Fornaro 
2013    Italy 
CS 
outpatien
ts 
MDD 
DSMIV, 18-
65yo, 
HAMD>18 
HC: no 
lifetime 
mood 
disorder, 
HAMD <7 
lifetime 
BD, 
cyclothym
ia, 
schizophr
enia, 
psychosis, 
Axis II or 
III 
comorbidi
ty,  
 
Depres
sed 
13  -  -  - 
HCL 
32 - 
182 
 - 87  - 
Greenwood 
2013      US, 
Canada 
CS 
outpatien
ts 
BD, 
MDD, or 
relatives 
of 
patients 
with BD, 
or 
relatives 
with 
MDD. 
HC: SCID 
ascertaine
d absence 
of disease 
 -  NA -  
10.0
0 
177..
00 
 -  - 
118..
00 
      
Harnic 2014        
Italy 
CS-
outpatien
ts 
BD I, II, 
DSM.IV, 
Euthymic 
HDRS <8 
YMRS <7, 
18-65,  
HC 
IQ<70, 
lifetime 
neurologi
cal 
disease, 
suicidal 
ideation, 
Euthym
ic 
 - 
15.0
0 
90..0
0 
 -  -  -  - 86..00  - 
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Country 
Design 
Inclusion 
Criteria for 
Primary 
Mood 
Disorder 
Patients 
Inclusion 
Criteria 
for 
Control 
Group 
Exclusion 
Criteria 
Illness 
Phase 
BD 
Illness 
Phase 
MDD 
NOS
-M 
N BD 
N 
BPD 
N 
ADH
D 
N 
MDD 
N 
Buli
mia 
or 
ANB
P 
N HC 
N 
Relati
ves 
unstable 
medical 
condition, 
blood 
exam 
alteration
s, 
substance 
abuse. 
Innamorati 
2015    Italy 
CS - 
inpatients 
BD-I or II 
DSM-IV,  
MDD 
Dementia, 
delirium 
NA NA 12 206     46  -  -  - 
Karam 2010    
Lebanon 
CS 
outpatien
ts 
Non 
institution
alized 
adults, 
meeting 
CIDI 
criteria for 
BD 
 -MDD, 
ADHD, HC 
 -  NA  - 9 18  - 6 64  - 384  - 
Kesebir 2005 
Turkey 
CS 
outpatien
ts 
BD I with 
or without 
family 
history for 
BD 
All 
matched 
for age, 
education
, gender 
from a 
previous 
study 
(Vahip et 
al, 2005) 
100 HC 
matched 
with 
patients 
with BD , 
219 first 
degree 
relative, 
and 219 
matched 
with 
relatives +  
 - 
Euthym
ic 
 - 
11.0
0 
100..
00 
 -  -  -  - 
100 
for 
BD, 
219 
for 
Relati
ves 
219 
Kesebir 2013           
Turkey 
CS 
outpatien
ts 
MDD DSM-
IV, 
remission,  
HC 
anxiety, 
somatofor
m, alcohol 
and 
substance 
abuse 
DSM-IV 
 - 
Euthym
ic 
13  -  -  - 100  - 100  - 
Kesebir 2014        
Turkey 
CS-
outpatien
ts 
BD I DSM-
IV, 
remission 
euthymic 
HDRS<8, 
YMRS<5 
MDD, HC 
Unstable 
medical 
condition, 
condition 
influencin
g uric 
acid, 
psychiatri
c 
comorbidi
ty 
Euthym
ic 
Euthym
ic 
14.0
0 
41..0
0 
 -  - 
30..0
0 
 - 43..00  - 
Mahon 2013         
US 
CS 
outpatien
ts 
BD I, II, 
NOS, 
clinically 
stable  
HC. 
Unaffecte
d sibling :  
>2 years  
older than 
bipolar 
 - 
Euthym
ic 
 - 
15.0
0 
55..0
0 
 -  -  -  - 
109..0
0 
51.00 
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Study / 
Country 
Design 
Inclusion 
Criteria for 
Primary 
Mood 
Disorder 
Patients 
Inclusion 
Criteria 
for 
Control 
Group 
Exclusion 
Criteria 
Illness 
Phase 
BD 
Illness 
Phase 
MDD 
NOS
-M 
N BD 
N 
BPD 
N 
ADH
D 
N 
MDD 
N 
Buli
mia 
or 
ANB
P 
N HC 
N 
Relati
ves 
onset age 
of 
patients 
and at 
least 25 - 
Matsumoto 
2005       
Japan 
CS 
outpatien
ts 
MDD, BD I, 
BD II, HRSD 
<10, MRS 
<12 
HC: No 
psychiatri
c illness 
influencin
g working 
function, 
CES-D < 
15 
Psychotic 
or organic 
disorder,  
Euthym
ic 
Euthym
ic 
16.0
0 
30..0
0 
 -  - 
29..0
0 
 - 59..00  - 
Mazzarini 
2009       
Italy 
CS 
inpatients 
BD I, II MDD  - NA- NA 8.00 
69..0
0 
 -  - 
19..0
0 
 -  -  - 
Mendlowicz 
2005    US 
CS 
outpatien
ts 
Recovered 
BD I or II 
(no 
symptoms 
or signs 2 
months),  
HC: 
normal 
controls + 
Relatives 
of Bipolar 
Bropands, 
at least w 
2 relatives 
w BD or 
BD + 
either 
schizoaffe
ctive or 
MDD. 
 - 
Euthym
ic 
 - 
12.0
0 
23..0
0 
 -  -  -  - 
102..0
0 
52.00 
Mendlowicz
2005b   US 
CS 
outpatien
ts 
Depressed 
BD I, BD II 
MDD  - 
Depres
sed 
Depres
sed 
12.0
0 
57..0
0 
 -  - 
94..0
0 
 -  -  - 
Nilsson 2010   
Denmark 
CS 
outpatien
ts 
BD, 
Female, 
Remission 
Bipolar (<6 
Bech 
Rafaelsen 
Mania 
Scale and 
<6 Bech 
Rafaelsen 
Melancholi
a Scale) 
Only 
female 
BPD 
Male 
Euthym
ic 
 - 13 25 31  -  -  - 29  - 
Nowakowsk
a 2005      US        
CS 
outpatien
ts 
BD, 
euthymic. 
MDD 
euthymic. 
HC: No 
history or 
family 
history of 
psychiatri
c illness, 
no drugs 
or 
Primmedi
cal 
problems, 
employed
, stable 
residency 
Psychiatri
c 
comorbidi
ty, active 
substance 
abuse, 
axis II 
personalit
y, 
or eating 
disorders 
Euthym
ic 
Euthym
ic 
13.0
0 
49..0
0 
 -  - 
25..0
0 
 - 47..00  - 
Pompili 
2014     Italy          
CS-
inpatients 
BD, DSM-
IV, >18 yo 
MDD, 
DSM-IV - 
Neurologi
cal 
disease,  
NA  NA 9.00 
288(B
DII 
202.. 
BDII 
 -  - 
96..0
0 
 -  -  - 
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Study / 
Country 
Design 
Inclusion 
Criteria for 
Primary 
Mood 
Disorder 
Patients 
Inclusion 
Criteria 
for 
Control 
Group 
Exclusion 
Criteria 
Illness 
Phase 
BD 
Illness 
Phase 
MDD 
NOS
-M 
N BD 
N 
BPD 
N 
ADH
D 
N 
MDD 
N 
Buli
mia 
or 
ANB
P 
N HC 
N 
Relati
ves 
86) 
Russo 2014           
US 
CS 
outpatien
t 
BD SCID, 
Euthymic 
HDRS <15 
CARS-M<8,  
18-65 
HC: SCID 
NP 
negative 
also for 1 
degree 
relatives, 
18-65 
Neurologi
cal 
disorder, 
ADHD, 
substance 
abuse 3 
months,  
active 
medical 
problem, 
ECT 12 
months 
Euthym
ic 
 - 14 64  -  -  -  - 109  - 
Rybakovsky 
2014      
Poland 
CS-
outpatien
ts 
BD I, BD II, 
DSM-IV  
 HC, 
Bulimia or 
ANBP 
 -  NA  - 8.00 
28..0
0 
 -  -  - 
28.0
0 
28..00  - 
Vazquez200
8               
Argentina 
CS 
outpatien
ts 
First 
degree 
relatives of 
BD 
patients  
HC: 
Healthy, 
with no 
family 
history of 
BD 
BD, <18 
yo 
   - 15  -  -  -  -  - 115 114 
Xu 2014            
China 
PR 2 
phases 
BD DSM-IV  
MDD, and 
SCL-90, 
HCL<8, 
HAM-D < 
6, HC 
pregnancy
, serious 
general 
medical 
illness, 
history of 
seizure 
disorder, 
DSMIV-TR 
defined 
organic 
mental 
disorders, 
dementia, 
schizophr
enia, 
delusional 
disorder, 
schizoaffe
ctive 
disorder, 
active 
substance 
use 
disorder, 
and 
history of 
mental 
retardatio
n. 
 NA NA 9 228  -  - 285  - 200  - 
7 
US/Cana
da, 6  
Italy, 4 
Turkey, 
1 Brazil, 
1 
Slovenia, 
1 
3 
included 
inpatients
, 22 
outpatien
ts, 1 in- 
and 
outpatien
ts 
23 BD, 1 
BD 
relatives, 2 
MDD 
13 MDD, 
17 HC, 1 
ED, 2 BPD, 
4 BD 
relatives, 
3 ADHD. 
 - 
BD: 13 
euthym
ic, 1 
depres
sed, 
others 
not 
declare
d.  
MDD: 7 
euthym
ic, 2 
depres
sed, 
others 
not 
declare
d.  
Mea
n 
NOS
-M 
=11.
46 
N BD 
= 
2025 
N 
BPD = 
43 
N 
ADHD 
= 56 
N 
MDD 
= 
1283 
N ED 
= 28 
N HC 
= 
1757 
N 
Healt
hy 
Relati
ves = 
436 
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Study / 
Country 
Design 
Inclusion 
Criteria for 
Primary 
Mood 
Disorder 
Patients 
Inclusion 
Criteria 
for 
Control 
Group 
Exclusion 
Criteria 
Illness 
Phase 
BD 
Illness 
Phase 
MDD 
NOS
-M 
N BD 
N 
BPD 
N 
ADH
D 
N 
MDD 
N 
Buli
mia 
or 
ANB
P 
N HC 
N 
Relati
ves 
Switzerl
and, 1 
Lebanon
, 1 Japan, 
1 
Denmar
k, 1 
Poland, 
1 
Argentin
a, 1 
China. 
 
Legend: ADHD: Attention Deficit Hyperactivity Disorder; ANBP: anorexia nervosa bulimic purgative; BD: bipolar 
disorder; BPD: borderline personality disorder; BPRS: brief psychiatric rating scale; CARS-M: clinician-administered 
rating scale for mania; CS: cross-sectional; DSM-IV: diagnostic and statistical manual, version IV; GAF: global 
assessment of functioning; HC: healthy control; HCL: hypomania check-list; HDRS: Hamilton depression rating scale; 
MDD: major depressive disorder; NOS: New Castle- Ottawa scale-Modified; PR: prospective; SCL-90: symptom check-
list 90; YMRS: Young mania rating scale. 
 
Table 2. Comparative meta-analysis of TEMPS score among Bipolar Disorder, Major Depressive Disorder, Attention Deficit and Hyperactivity 
Disorder, Borderline Personality Disorders, bipolar patients relatives, and healthy controls. 
Outcome or Subgroup Studies Participants Heterogeneity Effect Estimate * (p) Studies 
BD vs MDD   
1.1 Cyclothymic 12 2204 (P = 0.0009); I² = 65% 0.54 [0.38, 0.71] (P < 0.00001) 
Benazzi et al, 2006; DeAguiar 
et al, 2014; Dolenc et al, 2015; 
Greenwood et al, 2013; Karam 
et al, 2010; Kesebir et al, 2014; 
Matsumoto et al, 2005; 
Mazzarani et al, 2009; 
Mendlowicz et al, 2005b; 
Nowakowska et al, 2005; 
Pompili et al, 2014; Xu et al 
2014. 
1.2 Hyperthymic 12 2247 (P < 0.00001);I² = 78% 0.39 [0.18, 0.60] (P = 0.0002) 
1.3 Depressive 12 2247 (P < 0.00001);I² = 78%  -0.11 [-0.31, 0.09] (P = 0.29) 
1.4 Irritable 12 2247 (P < 0.0001); I² = 73%  0.41 [0.22, 0.60] (P < 0.0001) 
1.5 Anxious 10 1660 (P < 0.0001); I² = 79%  -0.08 [-0.32, 0.17] (P = 0.54) 
BD I vs BD II   
Outcome or Subgroup Studies Participants Heterogeneity Effect Estimate 
Evans et al, 2005; Pompili et al, 
2014; Xu et al, 2014 
2.1 Cyclothymic 3 671 (P = 0.21); I² = 36%  -0.11 [-0.31, 0.09] (p=0.29) 
2.2 Hyperthymic 3 671 (P = 0.49); I² = 0% 0.12 [-0.03, 0.28]  (P = 0.12) 
2.3 Depressive 3 671 (P = 0.61); I² = 0%  -0.25 [-0.41, -0.09] (P = 0.002) 
2.4 Irritable 3 671 (P = 0.34); I² = 7% 0.02 [-0.15, 0.18] (p=0.84) 
2.5 Anxious 2 443 (P = 0.40); I² = 0%  -0.04 [-0.23, 0.16] (p=0.72) 
BD vs HC   
Outcome or Subgroup Studies Participants Eterogeneity Effect Estimate 
Ecinki et al, 2013; Greenwood et 
al, 2013; Harnic et al, 2014; 
Karam et al, 2010; Kesebir et al, 
2005; Kesebir et al, 2014; 
Mahon et al, 2013; Matsumoto 
et al, 2005; Mendlowicz et al, 
2005; Nilsson et al, 2010; 
Nowakowska et al, 2005; Russo 
et al, 2014; Rybakowsky et al, 
2014; Xu et al, 2014. 
3.1 Cyclothymic 14 2452 (P < 0.00001); I² = 97% 2.22 [1.61, 2.84] (P < 0.00001) 
3.2 Hyperthymic 14 2452 (P < 0.00001); I² = 90%  -0.44 [-0.74, -0.15] (P = 0.004) 
3.3 Depressive 14 2452 (P < 0.00001); I² = 97% 1.19 [0.55, 1.82]  (P = 0.0002) 
3.4 Irritable 14 2452 (P < 0.00001); I² = 95% 1.29 [0.86, 1.72] (P < 0.00001) 
3.5 Anxious 12 1928 (P < 0.00001); I² = 97% 1.38 [0.66, 2.09] (P = 0.0002) 
26 
 
MDD vs HC   
Outcome or Subgroup Studies Participants Heterogeneity Effect Estimate 
Fornaro et al, 2013; Greenwood 
et al, 2013; Karam et al, 2010; 
Kesebir et al, 2013; Kesebir et al, 
2014; Matsumoto et al, 2005; 
Nowakowska et al, 2005; Xu et 
al, 2014. 
4.1 Cyclothymic 8 1901 (P < 0.00001); I² = 87% 0.90 [0.60, 1.20] (P < 0.00001) 
4.2 Hyperthymic 8 1901 (P = 0.01); I² = 61%  -0.68 [-0.85, -0.50] (P < 0.00001) 
4.3 Depressive 8 1901 (P < 0.00001); I² = 93% 1.29 [0.87, 1.71] (P < 0.00001) 
4.4 Irritable 8 1901 (P < 0.00001); I² = 95% 0.52 [0.04, 1.00] (P = 0.03) 
4.5 Anxious 6 1344 (P < 0.00001); I² = 93% 1.01 [0.53, 1.48] (P < 0.0001) 
BD vs OTHERS   
Outcome or Subgroup Studies Participants Eterogeneity Effect Estimate 
Benazzi et al, 2006; DeAguiar et 
al, 2014; Dolenc et al, 2015; 
Greenwood et al, 2013; Karam 
et al, 2010; Kesebir et al, 2014; 
Matsumoto et al, 2005; 
Mazzarani et al, 2009; 
Mendlowicz et al, 2005b; 
Nowakowska et al, 2005; 
Pompili et al, 2014; Xu et al 
2014; Ecinki et al, 2013; Eich et 
al 2014; Nilsson et al, 2010; 
Rybakowsky et al, 2014. 
5.1 Cyclothymic 16 2466 (P = 0.01), I² = 71.6% 
0.31 [0.09, 0.53] (P = 0.006)   
Subgroup differences (P = 0.01) 
  5.1.1 BD vs MDD 12 2204 (P = 0.0009); I² = 65% 0.54 [0.38, 0.71] (P < 0.00001) 
  5.1.2 BD vs ADHD 3 126 (P = 0.63); I² = 0% 0.14 [-0.22, 0.50] (P = 0.43) 
  5.1.3 BD vs 
Borderline 2 80 (P = 0.001); I² = 90%  -1.09 [-2.73, 0.55] (P = 0.19) 
  5.1.4 BD vs ED 1 56 NA  -0.04 [-0.56, 0.48] (p = 0.88) 
5.2 Hyperthymic 16 2509 
(P < 0.00001), I² = 
88.7% 
0.30 [0.10, 0.50] (P = 0.004); 
Subgroup differences (P < 
0.00001) 
  5.2.1 BD vs MDD 12 2247 (P < 0.00001); I² = 78% 0.39 [0.18, 0.60] (P = 0.0002) 
  5.2.2 BD vs ADHD 3 126 (P = 0.91); I² = 0%  -0.03 [-0.39, 0.33] (P = 0.86) 
  5.2.3 BD vs 
Borderline 2 80 (P = 0.81); I² = 0% 0.69 [0.23, 1.14] (P = 0.003) 
  5.2.4 BD vs ED 1 56 NA  -0.99 [-1.54, -0.43] (P = 0.0005) 
5.3 Depressive 16 2509 (P = 0.0002), I² = 84.8% 
 -0.18 [-0.37, 0.02] (P = 0.08); 
Subgroup differences (P = 
0.0002) 
  5.3.1 BD vs MDD 12 2247 (P < 0.00001); I² = 77%  -0.11 [-0.31, 0.09] (p = 0.03) 
  5.3.2 BD vs ADHD 3 126 (P = 0.12); I² = 53% 0.08 [-0.53, 0.69] (p = 0.79) 
  5.3.3 BD vs 
Borderline 2 80 (P = 0.67); I² = 0%  -1.24 [-1.73, -0.76] (P < 0.00001) 
  5.3.4 BD vs ED 1 56 NA  -0.04 [-0.57, 0.48] (p = 0.88) 
5.4 Irritable 16 2509 
(P < 0.00001), I² = 
91.3% 
0.16 [-0.05, 0.37] (P = 0.14);   
Subgroup differences (P < 
0.00001) 
  5.4.1 BD vs MDD 12 2247 (P < 0.0001); I² = 73% 0.41 [0.23, 0.60] (P < 0.0001) 
  5.4.2 BD vs ADHD 3 126 (P = 0.21); I² = 35%  -0.48 [-1.00, 0.03] (p = 0.07) 
  5.4.3 BD vs 
Borderline 2 80 (P = 0.46); I² = 0%  -0.91 [-1.38, -0.45] (P = 0.0001) 
  5.4.4 BD vs ED 1 56 NA  -0.14 [-0.67, 0.38] (p = 0.59) 
5.5 Anxious 14 1922 (P < 0.0001), I² = 87.0% 
 -0.24 [-0.48, 0.01] (P = 0.06); 
Subgroup differences (P < 
0.0001) 
  5.5.1 BD vs MDD 10 1660 (P < 0.00001); I² = 80%  -0.08 [-0.32, 0.17] (P = 0.54) 
  5.5.2 BD vs ADHD 3 126 (P = 0.12); I² = 53%  -0.26 [-0.88, 0.35] (P = 0.40) 
  5.5.3 BD vs 
Borderline 2 80 (P = 0.43); I² = 0%  -1.42 [-1.91, -0.92] (P < 0.00001) 
  5.5.4 BD vs ED 1 56 NA  -0.09 [-0.61, 0.44] (P = 0.74) 
BD vs RELATIVES   
Outcome or Subgroup Studies Participants Heterogeneity Effect Estimate 
Greenwood et al, 2013; Kesebir 
et al, 2005; Mahon et al, 2013; 
Mendlowicz et al, 2005 
6.1 Cyclothymic 4 795 (P < 0.00001); I² = 98% 2.89 [1.48, 4.29] (P < 0.0001) 
6.2 Hyperthymic 4 795 (P < 0.00001); I² = 94% 0.01 [-0.65, 0.68] (P = 0.97) 
6.3 Depressive 4 795 (P < 0.00001); I² = 97% 
1.16 [0.11, 2.21] (P = 0.03) Not 
significant after trim and fill. 
6.4 Irritable 4 795 (P < 0.00001); I² = 98% 1.90 [0.77, 3.04] (P = 0.001) 
6.5 Anxious 4 795 (P < 0.00001); I² = 99% 2.71 [0.23, 5.18] (P = 0.03) 
BD RELATIVES vs HC   
Outcome or Subgroup Studies Participants Heterogeneity Effect Estimate 
Greenwood et al, 2013; Kesebir 
et al, 2005; Mahon et al, 2013; 
Mendlowicz et al, 2005 
7.1 Cyclothymic 4 1018 (P < 0.00001); I² = 98% 1.54 [0.43, 2.65] (P = 0.007) 
7.2 Hyperthymic 4 1018 (P < 0.00001); I² = 97%  -0.61 [-1.36, 0.15] (P = 0.12) 
7.3 Depressive 4 1018 (P < 0.00001); I² = 99%  -0.03 [-1.41, 1.35] (P = 0.97) 
7.4 Irritable 4 1018 (P < 0.00001); I² = 97% 
0.67 [-0.10, 1.43] (P = 0.09); 0.98 
[0.48, 1.47] p=0.0001 after trim 
and fill 
7.5 Anxious 4 1018 (P < 0.00001); I² = 99% 
1.30 [-0.57, 3.17] (P = 0.17);  
2.11 [0.50, 3.72] p=0.01 after 
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trim and fill 
 
*Positive effect size indicates higher scores in the former group compared to the latter. 
Table 3.Meta-regression of moderators of TEMPS score in mood disorders. 
Moderator 
Number 
comparisons 
Β 95% CI P value R² 
1. BD vs. MDD 
1.1 Cyclothymic 
Country 
(Europe [ref] vs. 
 other continents) 
12 0.10 -0.24 0.44 0.57 0.00 
BD Phase:  
(Euthymic [ref] vs. 
depressed ) 
7 0.13 -0.54 0.80 0.70 0.00 
MDD Phase 
(Euthymic [ref] vs. 
depressed ) 
7 0.13 -0.54 0.80 0.70 0.00 
Males BD % 10 0.0003 -0.01 0.01 0.96 0.00 
Males MDD % 9 -0.010 -0.02 0.005 0.19 0.01 
1.2 Hyperthymic 
Country 
(Europe [ref] vs. 
 other continents) 
12 -0.44 -0.82 -0.06 0.02 0.28 
BD Phase:  
(Euthymic [ref] vs. 
depressed ) 
7 -0.41 -1.27 0.44 0.35 0.00 
MDD Phase 
(Euthymic [ref] vs. 
depressed ) 
7 -0.41 1.27 0.44 0.35 0.00 
Males BD % 10 -0.001 -0.02 0.03 0.91 0.00 
Males MDD % 9 -0.009 -0.03 0.01 0.41 0.00 
1.3 Depressive 
Country 
(Europe [ref] vs. 
 other continents) 
12 0.33 -0.08 0.74 0.12 0.03 
BD Phase:  
(Euthymic [ref] vs. 
depressed ) 
7 0.15 -0.63 0.94 0.70 0.00 
MDD Phase 
(Euthymic [ref] vs. 
depressed ) 
7 0.15 -0.63 0.94 0.70 0.00 
Males BD % 11 -0.02 -0.04 0.01 0.06 0.04 
Males MDD % 10 -0.003 -0.02 0.02 0.75 0.00 
1.4 Irritable 
Country 
(Europe [ref] vs. 
 other continents) 
12 -0.73 -2.07 0.68 0.28 0.00 
BD Phase:  
(Euthymic [ref] vs. 
6 -0.01 -2.60 2.58 0.99 0.00 
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Moderator 
Number 
comparisons 
Β 95% CI P value R² 
depressed ) 
MDD Phase 
(Euthymic [ref] vs. 
depressed ) 
6 -0.01 -2.60 2.58 0.99 0.00 
Males BD % 10 0.06 -0.01 0.12 0.11 0.00 
Males MDD % 9 0.04 -0.06 0.07 0.91 0.00 
1.5 Anxious 
Country 
(Europe [ref] vs. 
 other continents) 
10 -0.96 -2.00 0.09 0.07 0.00 
BD Phase:  
(Euthymic [ref] vs. 
depressed ) 
5 -0.74 -2.67 1.20 0.46 0.00 
MDD Phase 
(Euthymic [ref] vs. 
depressed ) 
5 -0.74 -2.67 1.20 0.46 0.00 
Males BD % 8 0.03 -0.03 0.08 0.33 0.00 
Males MDD % 7 -0.01 -0.06 0.04 0.64 0.00 
Males HS 0 studies available 
Males Sib 0 studies available 
Males HC % 2 studies available 
Males BD-I 2 studies available 
Males BD-II 1 studies available 
2.  BD vs. HC 
2.1 Cyclothymic 
Country 
(Europe [ref] vs. 
 other continents) 
14 1.00 -0.30 2.32 0.13 0.00 
BD Phase:  
(Euthymic [ref] vs. 
depressed ) 
All 11 studies euthymic phase  
Males BD % 12 0.03 -0.02 0.07 0.32 0.00 
Males HC % 10 0.05 0.01 0.08 0.01 0.00 
2.2 Hyperthymic 
Country 
(Europe [ref] vs. 
 other continents) 
14 -0.33 -0.96 0.31 0.32 0.00 
BD Phase:  
(Euthymic [ref] vs. 
depressed ) 
14 0.09 -0.72 0.89 0.84 0.00 
Males BD % 12 -0.008 -0.03 0.01 0.52 0.00 
Males HC % 10 -0.02 -0.04 0.008 0.20 0.00 
2.3 Depressive 
Country 
(Europe [ref] vs. 
 other continents) 
14 1.29 0.12 2.46 0.03 0.18 
BD Phase:  
(Euthymic [ref] vs. 
11 -0.32 -2.02 1.38 0.71 0.00 
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Moderator 
Number 
comparisons 
Β 95% CI P value R² 
depressed ) 
Males BD % 12 0.02 -0.03 0.07 0.42 0.00 
Males HC % 10 0.03 0.005 0.06 0.02 0.16 
2.4 Irritable  
Country 
(Europe [ref] vs. 
 other continents) 
14 1.00 0.20 1.81 0.01 0.18 
BD Phase:  
(Euthymic [ref] vs. 
depressed ) 
11 -0.48 -1.62 0.65 0.40 0.00 
Males BD % 12 0.02 -0.02 0.05 0.35 0.00 
Males HC % 10 0.31 -0.002 0.06 0.07 0.00 
2.5 Anxious 
Country 
(Europe [ref] vs. 
 other continents) 
12 1.87 0.75 3.00 0.001 0.40 
BD Phase:  
(Euthymic [ref] vs. 
depressed ) 
All 8 studies euthymic 
Males BD % 10 0.03 -0.02 0.08 0.23 0.00 
Males HC % 8 0.05 0.01 0.08 0.009 0.24 
3. MDD vs HC 
3.1 Cyclothymic 
Country 
(Europe [ref] vs. 
 other continents) 
8 0.56 0.03 1.14 0.04 0.24 
MDD Phase 
(Euthymic [ref] vs. 
depressed ) 
5 -0.62 -1.59 0.35 0.21 0.00 
Males MDD % 5 -0.003 -0.04 0.03 0.99 0.00 
Males HC % 6 0.01 -0.02 0.04 0.41 0.12 
3.2 Hyperthymic 
Country 
(Europe [ref] vs. 
 other continents) 
8 0.24 -0.08 0.57 0.15 0.28 
MDD Phase 
(Euthymic [ref] vs. 
depressed ) 
5 -0.18 -0.59 0.23 0.39 0.05 
Males MDD % 5 -0.002 -0.02 0.02 0.83 0.00 
Males HC % 6 0.003 -0.02 0.03 0.76 0.00 
3.3 Depressive 
Country 
(Europe [ref] vs. 
 other continents) 
8 -0.71 -1.51 0.10 0.08 0.18 
MDD Phase 
(Euthymic [ref] vs. 
depressed ) 
5 1.65 0.82 2.47 0.0001 0.75 
Males BD % 5 0.001 -0.001 0.03 0.32 0.00 
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Moderator 
Number 
comparisons 
Β 95% CI P value R² 
Males MDD % 5 0.0003 -0.06 0.06 1.00 0.00 
Males HC % 6 -0.01 -0.06 0.04 0.58 0.01 
3.4 Irritable  
Country 
(Europe [ref] vs. 
 other continents) 
8 0.74 -0.04 1.52 0.06 0.41 
MDD Phase 
(Euthymic [ref] vs. 
depressed ) 
5 -1.44 -2.30 -0.60 0.001 0.76 
Males MDD % 5 -0.010 -0.08 0.06 0.79 0.00 
Males HC % 6 0.007 -0.06 0.07 0.82 0.03 
3.5 Anxious 
Country 
(Europe [ref] vs. 
 other continents) 
6 0.82 0.14 1.50 0.02 0.55 
MDD Phase 
(Euthymic [ref] vs. 
depressed ) 
4 -1.03 -2.02 -0.04 0.04 0.43 
Males MDD % 3 studies available 
Males HC % 4 0.05 0.02 0.07 0.003 0.78 
4. BD vs Relatives  
4.1 Cyclothymic 
Country 
(Europe [ref] vs. 
 other continents) 
4 -0.17 -3.8 3.48 0.93 0.00 
BD Phase:  
(Euthymic [ref] vs. 
depressed ) 
4 -2.7 -6.36 0.97 0.15 0.00 
Males BD % 3      
Males HS 2 studies available 
Males Sib 1 study available 
4.2 Hyperthymic 
Country 
(Europe [ref] vs. 
 other continents) 
4 -0.64 -1.96 0.68 0.34 0.25 
BD Phase:  
(Euthymic [ref] vs. 
depressed ) 
4 0.98 0.09 1.87 0.03 0.68 
Males BD % 3 studies available 
Males HS 2 studies available 
Males Sib 1 study available 
4.3 Depressive 
Country 
(Europe [ref] vs. 
 other continents) 
4 -2.08 -5.02 0.87 0.17 0.00 
BD Phase:  
(Euthymic [ref] vs. 
depressed ) 
4 -1.17 -4.94 2.6 0.54 0.00 
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Moderator 
Number 
comparisons 
Β 95% CI P value R² 
Males BD % 3 studies available 
Males HS 2 studies available 
Males Sib 1 study available 
4.4 Irritable 
Country 
(Europe [ref] vs. 
 other continents) 
4 0.34 -2.51 3.19 0.82 0.00 
BD Phase:  
(Euthymic [ref] vs. 
depressed ) 
4 -1.65 -4.9 1.59 0.32 0.00 
Males BD % 3 studies available 
Males HS 2 studies available 
Males Sib 1 study available 
4.5 Anxious 
Country 
(Europe [ref] vs. 
 other continents) 
4 6.27 4.74 7.81 P<0.0001 0.94 
BD Phase:  
(Euthymic [ref] vs. 
depressed ) 
4 -2.89 -10.37 4.59 0.45 0.00 
Males BD % 3 studies available 
Males HS 2 studies available  
Males Sib 1 study available 
5. BD relatives vs Healthy Controls 
5.1 Cyclothymic 
Country 
(Europe [ref] vs. 
 other continents) 
4 -1.47 -4.85 1.9 0.39 0.00 
Males HS 2 studies available 
Males Sib 1 study available 
Males HC % 2 studies available 
5.2 Hyperthymic 
Country 
(Europe [ref] vs. 
 other continents) 
4 0.94 0.57 2.45 0.22 0.25 
Males HS 2 studies available 
Males Sib 1 study available 
Males HC % 2 studies available 
5.3 Depressive 
Country 
(Europe [ref] vs. 
 other continents) 
4 -2.08 -3.86 -0.29 0.02 0.69 
Males HS 2 studies available 
Males Sib 1 study available 
Males HC % 2 studies available 
5.4 Irritable 
Country 
(Europe [ref] vs. 
3 studies available 
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Moderator 
Number 
comparisons 
Β 95% CI P value R² 
 other continents) 
Males HS 3 studies available 
Males Sib 3 studies available 
Males HC % 3 studies available 
5.5 Anxious 
Country 
(Europe [ref] vs. 
 other continents) 
3 studies available 
Males HS 3 studies available 
Males Sib 3 studies available 
Males HC % 3 studies available 
 
Highlights 
 This is the first meta-analysis of TEMPS score across psychiatric disorders, their relatives, and 
healthy controls. 
 26 studies, 2,025 patients with BD, 1283 with MDD, 56 with ADHD, 43 with BPD, 436 relatives of 
BD, and 1757 HCs. 
  Cyclothymic (p<0.001) and irritable TEMPS scores (p<0.001) develop on a continuum, from HCs 
through MDD to BD.  
 Cyclothymic (p<0.001), irritable (p<0.001) and anxious (p=0.03) scores develop on a continuum from 
HCs, through BD relatives to BD. 
 
